Leveraging Organoids and Innovative Models to Predict Clinical Outcomes

• Explore the use of organoid systems to study local toxicity, deposition, and absorption patterns
• Examine how these models informed dosing, formulation, and delivery strategies for clinical trials
• Highlight lessons learned and best practices for integrating preclinical models into development programs

Speakers:

Sebastien Pradel

Senior Scientist, Translational Chemistry

AltPep Corporation